Enveric Biosciences, Inc. (ENVB) Earnings History
Net Loss32 years of earnings data (1994–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Enveric Biosciences, Inc. (ENVB) Earnings Overview
As of June 23, 2026, Enveric Biosciences, Inc. (ENVB) reported trailing twelve-month net income of -$8M, reflecting +84.1% year-over-year growth. The company earned $-5.44 per diluted share over the past four quarters.
Looking at the long-term picture, ENVB's historical earnings data spans multiple years. The company achieved its highest annual net income of $807,276 in fiscal 2007.
Enveric Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$179M net income), MNMD (-$238M net income), ATAI (-$663M net income, -16142.0% margin), ENVB has comparable earnings metrics. Compare ENVB vs CMPS →
ENVB Earnings vs Peers
Earnings metrics vs comparable public companies
ENVB Historical Earnings Data (1994–2025)
32 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$12M | -26.7% | -$9M | $-36.24 | - | - |
| 2024 | -$10M | -55272.4% | -$10M | $-228.48 | - | - |
| 2023 | $-17,292 | +99.9% | -$16M | $-97.08 | - | - |
| 2022 | -$19M | +62.2% | -$20M | $-156.00 | - | - |
| 2021 | -$49M | -613.5% | -$26M | $-1244.28 | - | - |
| 2020 | -$7M | -22.5% | -$6M | $-666.00 | - | - |
| 2019 | -$6M | +66.8% | -$6M | $-2543.88 | -14.0% | -15.8% |
| 2018 | -$17M | -86.2% | -$7M | $-42616.68 | -39.3% | -16.6% |
| 2017 | -$9M | -226.4% | -$12M | $-36347.76 | -18.7% | -24.6% |
| 2016 | -$3M | -47.1% | -$5M | $-12770.04 | -7.7% | -14.9% |
| 2015 | -$2M | -5519.9% | -$2M | $-10220.28 | -11.8% | -11.7% |
| 2014 | $-33,644 | -20796.9% | $-32,811 | $-2307.00 | - | - |
| 2013 | $-161 | +99.3% | $-27,211 | $-14.16 | - | - |
| 2012 | $-24,621 | +26.2% | $-22,690 | $-2156.64 | - | - |
| 2011 | $-33,380 | +15.4% | $-31,395 | $-2923.80 | - | - |
| 2010 | $-39,441 | +32.6% | $-35,875 | $-6483.48 | - | - |
| 2009 | $-58,544 | +59.2% | $-55,569 | $-9623.64 | - | - |
| 2008 | $-143,636 | -117.8% | $-151,441 | $-23611.44 | - | - |
| 2007 | $807,276 | +328.9% | $253,770 | $132696.00 | 107.5% | 33.8% |
| 2006 | $-352,626 | -332.6% | $-353,541 | $-76936.56 | -105.8% | -106.1% |
| 2005 | $-81,515 | +48.2% | $-90,350 | $-17785.08 | -6.8% | -7.6% |
| 2004 | $-157,490 | +68.2% | $-151,777 | $-35658.12 | -14.2% | -13.7% |
| 2003 | $-495,453 | -2808.6% | $-483,787 | $-112178.04 | -39.0% | -38.1% |
| 2002 | $18,292 | +107.6% | $14,228 | $4141.56 | 1.0% | 0.8% |
| 2001 | $-240,107 | -162.9% | $-315,771 | $-54363.84 | -15.0% | -19.7% |
| 2000 | $382,019 | +7.7% | $358,134 | $86494.92 | 17.4% | 16.3% |
| 1999 | $354,792 | +106.1% | $455,555 | $81875.04 | 21.4% | 27.4% |
| 1998 | -$6M | -22.7% | -$2M | $-999999.00 | -344.8% | -115.7% |
| 1997 | -$5M | +81.4% | -$5M | $-999999.00 | -169.7% | -168.5% |
| 1996 | -$25M | -693.6% | -$25M | $-999999.00 | -1254.6% | -1245.1% |
| 1995 | -$3M | -166.7% | -$3M | $-999999.00 | -266.7% | -275.0% |
| 1994 | -$1M | - | -$1M | $-847058.88 | -600.0% | -550.0% |
Download Data
Export ENVB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
32+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ENVB — Frequently Asked Questions
Quick answers to the most common questions about buying ENVB stock.
What is ENVB earnings per share (EPS)?
ENVB trailing twelve-month (TTM) diluted EPS is $-5.44, reflecting +84.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1994 to 2025 is available in the table on this page.
What is Enveric Biosciences, Inc.'s net income?
Enveric Biosciences, Inc. (ENVB) trailing twelve-month net income is $-8M as of 2025. Earnings grew +84.1% year-over-year.
Is ENVB profitable?
ENVB is not currently profitable on a TTM basis, reporting a net loss of $-8M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ENVB's earnings growth rate?
ENVB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1994 to 2025.
What are ENVB's profit margins?
Enveric Biosciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -420.5%.
Is ENVB growing earnings?
Yes, ENVB earnings are accelerating — EPS growth of +84.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-8M. Earnings momentum is strengthening.
What was ENVB's best earnings year?
Enveric Biosciences, Inc.'s highest annual net income on record is $807276.00, achieved in fiscal year 2007. Earnings history on this page spans 1994 to 2025 and includes all annual and quarterly figures.
What were ENVB's earnings last quarter?
ENVB's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-1.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.